Ana L. Creo

1.0k total citations
37 papers, 643 citations indexed

About

Ana L. Creo is a scholar working on Endocrinology, Diabetes and Metabolism, Surgery and Molecular Biology. According to data from OpenAlex, Ana L. Creo has authored 37 papers receiving a total of 643 indexed citations (citations by other indexed papers that have themselves been cited), including 13 papers in Endocrinology, Diabetes and Metabolism, 11 papers in Surgery and 7 papers in Molecular Biology. Recurrent topics in Ana L. Creo's work include Vitamin D Research Studies (5 papers), Diabetes Management and Research (5 papers) and Electrolyte and hormonal disorders (5 papers). Ana L. Creo is often cited by papers focused on Vitamin D Research Studies (5 papers), Diabetes Management and Research (5 papers) and Electrolyte and hormonal disorders (5 papers). Ana L. Creo collaborates with scholars based in United States, South Africa and Canada. Ana L. Creo's co-authors include W. Schwenk, Gregory N. Ruegsegger, Tiffany Cortes, Surendra Dasari, K. Sreekumaran Nair, John Μ. Pettifor, Tom D. Thacher, Philip R. Fischer, Peter J. Tebben and Mark Strand and has published in prestigious journals such as Journal of Clinical Investigation, PEDIATRICS and Diabetes.

In The Last Decade

Ana L. Creo

36 papers receiving 633 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Ana L. Creo United States 11 169 134 130 128 119 37 643
Haïfa Maalmi Germany 15 213 1.3× 114 0.9× 82 0.6× 171 1.3× 141 1.2× 34 709
Elena Grineva Russia 17 157 0.9× 136 1.0× 70 0.5× 220 1.7× 93 0.8× 104 787
Seda Sancak Türkiye 14 329 1.9× 88 0.7× 146 1.1× 228 1.8× 90 0.8× 48 805
Venkat Parameswaran Australia 9 224 1.3× 119 0.9× 81 0.6× 138 1.1× 129 1.1× 16 747
Julio C. Sartori‐Valinotti United States 17 111 0.7× 108 0.8× 92 0.7× 232 1.8× 232 1.9× 51 899
Min Sun China 17 104 0.6× 178 1.3× 60 0.5× 266 2.1× 92 0.8× 68 844
Samim Ali Mondal India 11 102 0.6× 111 0.8× 47 0.4× 106 0.8× 128 1.1× 27 548
D. Maugeri Italy 14 230 1.4× 128 1.0× 106 0.8× 105 0.8× 104 0.9× 60 841
Laura M.G. Meems Netherlands 16 130 0.8× 112 0.8× 46 0.4× 85 0.7× 105 0.9× 27 710
Zbigniew Bartoszewicz Poland 15 97 0.6× 97 0.7× 69 0.5× 110 0.9× 173 1.5× 46 615

Countries citing papers authored by Ana L. Creo

Since Specialization
Citations

This map shows the geographic impact of Ana L. Creo's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Ana L. Creo with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Ana L. Creo more than expected).

Fields of papers citing papers by Ana L. Creo

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Ana L. Creo. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Ana L. Creo. The network helps show where Ana L. Creo may publish in the future.

Co-authorship network of co-authors of Ana L. Creo

This figure shows the co-authorship network connecting the top 25 collaborators of Ana L. Creo. A scholar is included among the top collaborators of Ana L. Creo based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Ana L. Creo. Ana L. Creo is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Joshi, Avni Y., et al.. (2024). Seroconversion following PPSV23 vaccination in children with type 1 diabetes mellitus. Vaccine. 45. 126592–126592. 1 indexed citations
2.
Jackson, Sarah E., et al.. (2023). Oral Glucose Tolerance Testing Using Candy: A Sweet Solution to Improve Screening in Children with Cystic Fibrosis?. Children. 10(8). 1317–1317. 1 indexed citations
3.
Salama, Mostafa A., et al.. (2023). Adolescents with Type 2 Diabetes: Overcoming Barriers to Effective Weight Management. Diabetes Metabolic Syndrome and Obesity. Volume 16. 693–711. 6 indexed citations
4.
Pittock, Siobhán T., et al.. (2023). Exogenous Insulin Antibody Syndrome in a Pediatric Patient: Successful Treatment with Mycophenolate Mofetil. Hormone Research in Paediatrics. 97(3). 303–310. 1 indexed citations
5.
Heien, Herbert C., Herbert C. Heien, Ana L. Creo, et al.. (2023). Glucagon fill rates and cost among children and adolescents with type 1 diabetes in the United States, 2011–2021. Diabetes Research and Clinical Practice. 206. 111026–111026. 2 indexed citations
6.
Nofal, Alaa Al, Christian Hanna, Aida Lteif, et al.. (2023). Copeptin levels in hospitalized infants and children with suspected vasopressin-dependent disorders: a case series. Journal of Pediatric Endocrinology and Metabolism. 36(5). 492–499. 5 indexed citations
7.
Sas, David J., Imad Absah, Sean M. Phelan, et al.. (2022). Patient Satisfaction Scores Impact Pediatrician Practice Patterns, Job Satisfaction, and Burnout. Clinical Pediatrics. 62(7). 769–780. 3 indexed citations
8.
Pittock, Siobhán T., et al.. (2022). 149-LB: Pediatric Exogenous Insulin Antibody Syndrome—Successful Treatment with Mycophenolate Mofetil. Diabetes. 71(Supplement_1). 1 indexed citations
9.
Creo, Ana L., Siobhán T. Pittock, & Nusheen Ameenuddin. (2022). Reframing “Normal” Puberty: Pivoting From a White Standard. Journal of Adolescent Health. 71(1). 8–9. 1 indexed citations
10.
Creo, Ana L., et al.. (2021). Ovarian Steroid Cell Tumor Masquerading as Steroid-Unresponsive Congenital Adrenal Hyperplasia. AACE Clinical Case Reports. 7(4). 261–263. 2 indexed citations
12.
Creo, Ana L., Tiffany Cortes, Hang Joon Jo, et al.. (2021). Brain functions and cognition on transient insulin deprivation in type 1 diabetes. JCI Insight. 6(5). 14 indexed citations
13.
Wang, Zhen, Avni Y. Joshi, Sarah Jackson, et al.. (2021). Association of vitamin D deficiency with COVID‐19 infection severity: Systematic review and meta‐analysis. Clinical Endocrinology. 96(3). 281–287. 74 indexed citations
14.
Thacher, Tom D., John Μ. Pettifor, Peter J. Tebben, et al.. (2019). Rickets severity predicts clinical outcomes in children with X-linked hypophosphatemia: Utility of the radiographic Rickets Severity Score. Bone. 122. 76–81. 48 indexed citations
15.
Creo, Ana L., Bryan C. Cannon, Aida Lteif, et al.. (2019). Patterns of amiodarone-induced thyroid dysfunction in infants and children. Heart Rhythm. 16(9). 1436–1442. 8 indexed citations
16.
Creo, Ana L., Fares Alahdab, Alaa Al Nofal, et al.. (2018). Diagnostic accuracy of the McGill thyroid nodule score in paediatric patients. Clinical Endocrinology. 90(1). 200–207. 7 indexed citations
17.
Creo, Ana L., Fares Alahdab, Alaa Al Nofal, et al.. (2018). Ultrasonography and the American Thyroid Association Ultrasound-Based Risk Stratification Tool: Utility in Pediatric and Adolescent Thyroid Nodules. Hormone Research in Paediatrics. 90(2). 93–101. 30 indexed citations
18.
Creo, Ana L., et al.. (2018). Productive Pumping: A Pilot Study to Help Postpartum Residents Increase Clinical Time. Journal of Graduate Medical Education. 10(2). 223–225. 10 indexed citations
19.
Creo, Ana L., Tom D. Thacher, John Μ. Pettifor, Mark Strand, & Philip R. Fischer. (2016). Nutritional rickets around the world: an update. Paediatrics and International Child Health. 37(2). 84–98. 93 indexed citations
20.
Creo, Ana L., et al.. (2013). Vitamin D levels, insulin resistance, and cardiovascular risks in very young obese children. Journal of Pediatric Endocrinology and Metabolism. 26(1-2). 97–104. 24 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026